Form 4 for SLS SELLAS Life Sciences Group, Inc.
Accepted 2025-01-14 00:00:00 ET · period of report 2025-01-10 · accession 0001104659-25-003501 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-01-14 | 2025-01-10 | SLS | Stergiou Angelos M. | Pres, CEO, Dir | A - Grant | $0.00 | +500.9K | 615.1K | +438% | $0 |
| D | 2025-01-14 | 2025-01-10 | SLS | Stergiou Angelos M. | Pres, CEO, Dir | A - Grant | $0.00 | +385.8K | 385.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-10 | A | A | 243,900 | $0.00 | 859,032 | D | — | — | (F2) The Reporting Person received an award of 243,900 restricted stock units on January 10, 2025, which shall vest in full on December 1, 2025, provided that the Reporting Person remains in service with the Issuer through each such vesting date. |
| 2 | Common | Common Stock | 2025-01-10 | A | A | 257,000 | $0.00 | 615,132 | D | — | — | (F1) The Reporting Person received an award of 257,000 restricted stock units on January 10, 2025, which shall vest as follows: (i) 25% on December 1, 2025 and (ii) 25% on each December 1 thereafter until fully vested, provided that the Reporting Person remains in service with the Issuer through each such vesting date. |
| 3 | Derivative | Stock Option (Right to Buy) | 2025-01-10 | A | A | 385,750 | $0.00 | 385,750 | D | $0.95 · — to 2035-01-10 | 385,750 Common Stock | (F3) One-quarter (1/4) of the option shares will vest and became exercisable one year from the January 10, 2025 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date. |